Biotechnology ASX Stock News and Announcements

31 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Cambium Bio announces merger completion and updates on Elate Ocular® Phase 3 trials.

Cambium Bio Regenerative Medicine Stock Market News Clinical Trials Biotechnology

Posted on: 31/07/2024

Read More

23 July 2024

Quarterly Appendix 4C and Activities Report

Dimerix reports significant progress in DMX-200 licensing and clinical trials.

Dimerix Biopharmaceuticals Clinical Trials Stock Market News DMX-200

Posted on: 23/07/2024

Read More